The evidence comb
12 cells, filled by how much research actually backs each one
The colored bar at the top of each cell is not decorative artwork. It represents our editorial evidence score (from 50% to 90%) measuring how directly published, peer-reviewed human clinical trials (PubMed, RCTs) support that active nutrient for glycemic and metabolic pathways.
Cell 01 · Research Weight 85%
Chromium Picolinate
0.7 mcg
Extensive meta-analyses of double-blind, placebo-controlled human trials demonstrate that chromium serves as an indispensable co-factor for insulin receptor phosphorylation, enhancing intracellular glucose uptake. While clinical intervention studies often examine 200–1000 mcg doses for acute glycemic support, Olivaro provides a micro-nutritional baseline of 0.7 mcg to safely complement daily cellular chromium pools.
Clinical Verdict: Validated physiological co-factor for insulin sensitivity; transparently disclosed at 0.7 mcg on the official label.
Cell 02 · Research Weight 80%
Gymnema Sylvestre Leaf Extract
Undisclosed proprietary blend amount
Known in Ayurvedic pharmacopeia as 'Gurmar', gymnemic acids physically bind to intestinal brush border receptors to blunt glucose absorption while temporarily desensitizing lingual sweet taste receptors. Human trials indicate significant reductions in postprandial glucose spikes and fasting blood sugar over 12 weeks.
Clinical Verdict: Strong clinical literature backing gut-level sugar attenuation; exact milligram amount is proprietary within the 200 mg matrix.
Cell 03 · Research Weight 75%
African Mango Seed Extract
Undisclosed proprietary blend amount
Clinical evaluations demonstrate that Irvingia gabonensis seeds modulate leptin resistance and stimulate adiponectin secretion, directly supporting carbohydrate metabolism and reducing ectopic visceral fat accumulation in overweight participants across 10-week randomized trials.
Clinical Verdict: Established trial evidence for metabolic hormonal signaling; individual milligram fraction undisclosed on label.
Cell 04 · Research Weight 75%
Green Tea Leaf Extract
Undisclosed proprietary blend amount
Rich in epigallocatechin gallate (EGCG), green tea catechins mitigate pancreatic beta-cell oxidative exhaustion, optimize peripheral glucose disposal, and support gentle metabolic thermogenesis without cardiovascular volatility.
Clinical Verdict: Robust clinical data for cellular antioxidant defense against glucotoxicity; concentration withheld within proprietary blend.
Cell 05 · Research Weight 65%
Maca Root Extract
Undisclosed proprietary blend amount
High-altitude adaptogen clinically studied for modulating the hypothalamic-pituitary-adrenal (HPA) axis, attenuating diurnal cortisol elevation—a key biochemical trigger of hepatic gluconeogenesis and stubborn morning fasting glucose spikes.
Clinical Verdict: Favorable evidence for adrenal and neuroendocrine stability; provided as concentrated botanical extract.
Cell 06 · Research Weight 70%
Panax Ginseng Aerial Extract
Undisclosed proprietary blend amount
Human RCTs indicate Panax ginsenosides stimulate GLUT4 glucose transporter translocation in skeletal muscle via AMPK pathway activation, facilitating non-insulin dependent glucose clearance while mitigating chronic fatigue associated with glycemic instability.
Clinical Verdict: Validated AMPK and peripheral glucose disposal mechanism; individual dose undisclosed.
Cell 07 · Research Weight 60%
Guarana Seed Extract
Undisclosed proprietary blend amount
Provides gentle, slow-release botanical xanthines that pair synergistically with catechins to promote metabolic turnover and cellular alertness without the harsh autonomic rebound associated with synthetic caffeine.
Clinical Verdict: Effective metabolic co-factor; present in subtle micro-concentrations within the blend.
Cell 08 · Research Weight 60%
Coleus Forskohlii Root Extract
Undisclosed proprietary blend amount
Forskolin directly activates adenylate cyclase enzyme, raising intracellular cyclic AMP (cAMP) levels to promote lipase breakdown and cellular energy utilization without beta-adrenergic stimulation.
Clinical Verdict: Established intracellular messenger mechanism; exact extract potency withheld.
Cell 09 · Research Weight 65%
Astragalus Root Extract
Undisclosed proprietary blend amount
Contains specific astragalosides documented in peer-reviewed journals for protecting microvascular pericytes, supporting renal microcirculation, and preserving capillary integrity under chronic glycemic stress.
Clinical Verdict: Valuable microvascular protective botanical; formulated as part of the overall supportive blend.
Cell 10 · Research Weight 70%
Grape Seed Extract
Undisclosed proprietary blend amount
High-potency polyphenolic OPCs protect vascular collagen matrices from Advanced Glycation End-products (AGEs), helping maintain arterial compliance and healthy blood flow to extremities.
Clinical Verdict: Strong biochemical rationale for microvascular and endothelial protection; amount undisclosed.
Cell 11 · Research Weight 55%
Deglycyrrhizinated Licorice Extract
Undisclosed proprietary blend amount
Formulated to soothe sublingual and gastric mucosa during liquid drop absorption while supporting healthy mucosal barrier function, with glycyrrhizin removed to avoid mineralocorticoid hypertension risks.
Clinical Verdict: Protective delivery aid for digestive mucosal tolerance; low concentration contribution.
Cell 12 · Research Weight 65%
L-Carnitine & L-Glutamine Complex
Undisclosed proprietary blend amount
L-Carnitine facilitates long-chain fatty acid transport into mitochondrial matrices for beta-oxidation, while L-Glutamine supports intestinal tight junction integrity and diminishes intense carbohydrate cravings.
Clinical Verdict: Synergistic mitochondrial and enterocyte support; individual milligram amounts kept proprietary.
